Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6-month therapy study with coenzyme Q

European Neurology

Volumn 36, Issue 4, 1996, Pages 191-196

  Gold, R ^a   Seibel, P ^a   Reinelt, G ^a   Schindler, R ^a   Landwehr, H ^a   Beck, A ^a   Reichmann, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

31P magnetic resonance spectroscopy; Coenzyme Q10<; Mitochondrial myopathy; Mtdna deletion

Indexed keywords

CREATINE PHOSPHATE; PHOSPHATE; PHOSPHORUS 31; UBIDECARENONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ENCEPHALOMYOPATHY; EXERCISE; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; MALE; MITOCHONDRIAL MYOPATHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; ENERGY METABOLISM; EXERCISE TEST; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES; PHOSPHOCREATINE; PHOSPHORUS; STATISTICS, NONPARAMETRIC; UBIQUINONE;

EID: 0029948495     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117246     Document Type: Article

References (14)

1. Vloracs CF, DiMauro S, Zeviani M, Lombes A shanske S, Miranda AF, Nakase H, Bonilla E Wcrneck LC, Servidei S, Nonaka I, Koga Y Spiro AJ, Brownell AKW, Schmidl B, Scholand DL, Zupanc M, De Viro DC, Schon EA Rowland LP; Mitochondrial DNA deletions ii progressive external ophthalmoplegia ant Kearns-Sayre syndrome, N Engl J Med 1989 320:1293-1299.
2. Goto YI, Nonaka I, Horai S: A mutation in tin iRNA Leu(UUR) gene associated with thi MELAS subgroup of mitochondrial encephalo myopathies, Nature 1990;348:651-653.
3. Reichmann H, Degoul F, Gold R, Meurers B Ketelsen UP, Hartmann J, Marsac C, Les tienne P: Histological, enzymatic and mito ehondrial DNA studies in patients witl Keams-Sayrc syndrome and chronic progrès sivc external ophthalmoplegia, Eur Neuro 1991;31:108-113.
4. Holt IJ, Harding AE, Morgan-Hughes JA: De Ictions of muscle mitochondrial DNA in pa tients with mitochondrial myopathies, Naturi 1988;331:717-719.
5. Ogasahara S, Nishikawa Y, Yorifuji S, Soga F, Nakamura Y, Takahashi M, Hashimoto S, Kono N, Tarui N: Treatment of Keams-Sayre syndrome with coenzyme Q 10. Neurology 1986:36:45-53.
6. Nakamura T, Sanma H, Himeno M, Kalo K: Transfer of exogenous cocnzyme Q 10 to the inner membrane of heart mitochondria in rats; in Yamamura Y, Folkcrs K, Ito Y (eds): Biomedical and Clinical Aspects of Cocnzyme Q, ed 1. Amsterdam, Elsevier, 1980. pp 3-14.
7. Bresolin N, Bet L, Binda A, Moggio M, Conti G, Nador F, Ferrante C, Carenzi A, Scarlato G: Clinical and biochemical correlations in mitochondrial myopathies treated with cocnzyme 0 10. Neurology 1988:38:892-899.
8. Bresolin N, Doriguzzi C, Ponzetto C, Angelini C, Moroni I, Castelli E, Cossutta E, Binda A, Gallanti A, Gabellini S: Ubidecarenone in the treatment of mitochondrial myopathies: A multicenter double-blind trial, J Neurol Sci 1990:100:70-78.
9. 31P NMR study, Neurology 1989:39:399- 403.
10. Zierz S, von Wersebe O, Bleistein J, Jerusalem F: Exogenous cocnzyme Q fails to increase CoQ in skeletal muscles of two patients with mitochondrial myopathies, J Neurol Sei 1990; 95:283-290.
11. 3IP MRS) in neuromuscular disorders, Ann Neurol 1991;30:90-97.
12. 3IP Spektroskopie der Skelettmuskulatur unter Belastung: Technische Vorraussetzungen und erste Ergebnisse, Röntgenstrahlcn 1991:66:14.
13. Piccolo G, Banfi P, Azan G, Rizzuto R, Bisson R, Sandona D, Bellomo G: Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia, J Neurol Sei 1991:105:57-60.
14. 11P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzvmc Q in mitochondrial myopathies, Neurology 1992:42:1203- 1208